array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(29) "Becton, Dickinson and Company"
["slug"]=>
string(37) "4601d-us-becton-dickinson-and-company"
["logo"]=>
NULL
["description"]=>
NULL
["address_street"]=>
string(11) "1 Becton Dr"
["address_place"]=>
string(14) "Franklin Lakes"
["address_region"]=>
string(10) "New Jersey"
["founding_date"]=>
string(10) "1897-02-28"
["website_domain"]=>
string(6) "bd.com"
["website_url"]=>
string(18) "https://www.bd.com"
["industry_codes"]=>
array(2) {
[0]=>
string(46) "Surgical and Medical Instruments and Apparatus"
[1]=>
string(60) "Orthopedic, Prosthetic, and Surgical Appliances and Supplies"
}
["employee_count"]=>
int(1500)
["article_count"]=>
int(417)
}
["articles"]=>
array(4) {
[0]=>
array(7) {
["title_en"]=>
string(109) "With 90% institutional ownership, Becton, Dickinson and Company (NYSE:BDX) is a favorite amongst the big guns"
["snippet_en"]=>
string(121) "Key Insights Given the large stake in the stock by institutions, Becton Dickinson's stock price might be vulnerable to..."
["url"]=>
string(84) "https://au.news.yahoo.com/90-institutional-ownership-becton-dickinson-130022702.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/f5b29773-3cca-4d1f-9924-f45a2e206e09"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-09-29"
["categories"]=>
array(5) {
[0]=>
string(12) "Stock Market"
[1]=>
string(21) "Competitive Behaviour"
[2]=>
string(15) "Market Movement"
[3]=>
string(18) "General Investment"
[4]=>
string(24) "Stock Research & Ratings"
}
}
[1]=>
array(7) {
["title_en"]=>
string(85) "Raymond James Lowers Becton, Dickinson and Company (NYSE:BDX) Price Target to $304.00"
["snippet_en"]=>
string(297) "Becton, Dickinson and Company (NYSE:BDX – Free Report) had its price target reduced by Raymond James from $305.00 to $304.00 in a research report report published on Friday morning, Benzinga reports. Raymond James currently has an outperform rating on the medical instruments supplier’s stock."
["url"]=>
string(124) "http://www.defenseworld.net/2023/08/08/raymond-james-lowers-becton-dickinson-and-company-nysebdx-price-target-to-304-00.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/b220e2fa-d3cf-42e3-a28b-fe58c2d123b4"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2023-08-08"
["categories"]=>
array(4) {
[0]=>
string(21) "Competitive Behaviour"
[1]=>
string(24) "Stock Research & Ratings"
[2]=>
string(12) "Stock Market"
[3]=>
string(17) "Academic Research"
}
}
[2]=>
array(7) {
["title_en"]=>
string(109) "With 90% institutional ownership, Becton, Dickinson and Company (NYSE:BDX) is a favorite amongst the big guns"
["snippet_en"]=>
string(121) "Key Insights Given the large stake in the stock by institutions, Becton Dickinson's stock price might be vulnerable to..."
["url"]=>
string(86) "https://uk.movies.yahoo.com/90-institutional-ownership-becton-dickinson-120120512.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/e737a4bc-ab81-45be-8a45-de98a0746079"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-07-16"
["categories"]=>
array(2) {
[0]=>
string(21) "Competitive Behaviour"
[1]=>
string(12) "Stock Market"
}
}
[3]=>
array(7) {
["title_en"]=>
string(84) "Medtech firm BD dives into growing pharmacy automation market with $1.5B acquisition"
["snippet_en"]=>
string(297) "Hungry for a slice of the budding pharmacy automation market, medical technology firm Becton, Dickinson and Company announced today plans to acquire Parata Systems for more than $1.5 billion. | BD 's acquisition of Parata Systems gives the medtech firm access to a$ 600 million pharmacy automation"
["url"]=>
string(117) "https://www.fiercehealthcare.com/health-tech/medtech-firm-bd-dives-growing-pharmacy-automation-market-15b-acquisition"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/aa189ca0-3ecf-41c1-a61f-b203278dc070"
["source"]=>
string(20) "fiercehealthcare.com"
["publication_date"]=>
string(10) "2022-06-06"
["categories"]=>
array(4) {
[0]=>
string(25) "Business Model Resilience"
[1]=>
string(21) "Competitive Behaviour"
[2]=>
string(18) "Expansion & Growth"
[3]=>
string(11) "Acquisition"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(44)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(26)
}
[2]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(20)
}
[3]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(20)
}
[4]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(20)
}
[5]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(20)
}
[6]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(17)
}
[7]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(15)
}
[8]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(15)
}
[9]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(14)
}
[10]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(13)
}
[11]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(12)
}
[12]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(12)
}
[13]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(11)
}
[14]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(9)
}
[15]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(8)
}
[16]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(8)
}
[17]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(8)
}
[18]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(7)
}
[19]=>
array(2) {
["name"]=>
string(14) "Product Recall"
["count"]=>
int(6)
}
[20]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(6)
}
[21]=>
array(2) {
["name"]=>
string(25) "Leadership and Governance"
["count"]=>
int(5)
}
[22]=>
array(2) {
["name"]=>
string(16) "Case Settlements"
["count"]=>
int(5)
}
[23]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(5)
}
[24]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(5)
}
[25]=>
array(2) {
["name"]=>
string(21) "Cultural developments"
["count"]=>
int(4)
}
[26]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(4)
}
[27]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(4)
}
[28]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(4)
}
[29]=>
array(2) {
["name"]=>
string(19) "Green & Responsible"
["count"]=>
int(4)
}
}
}
4601d-us-becton-dickinson-and-company
Becton, Dickinson and Company
Website
https://www.bd.com
Category
Surgical and Medical Instruments and Apparatus
Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Articles
2023-09-29 (yahoo.com)
Key Insights Given the large stake in the stock by institutions, Becton Dickinson's stock price might be vulnerable to...
Read more
2023-08-08 (defenseworld.net)
Becton, Dickinson and Company (NYSE:BDX – Free Report) had its price target reduced by Raymond James from $305.00 to $304.00 in a research report report published on Friday morning, Benzinga reports. Raymond James currently has an outperform rating on the medical instruments supplier’s stock.
Read more
2023-07-16 (yahoo.com)
Key Insights Given the large stake in the stock by institutions, Becton Dickinson's stock price might be vulnerable to...
Read more
2022-06-06 (fiercehealthcare.com)
Hungry for a slice of the budding pharmacy automation market, medical technology firm Becton, Dickinson and Company announced today plans to acquire Parata Systems for more than $1.5 billion. | BD 's acquisition of Parata Systems gives the medtech firm access to a$ 600 million pharmacy automation
Read more
Newsletter subscription
Notice: JavaScript is required for this content.